MANAGEMENT

chief executive officer & Chief Financial Officer Ronny Skuggedal

Mr. Skuggedal joined PCI Biotech in October 2013 as CFO with responsibility for finance, accounting and investor relations, and with a key role in business development. Ronny was appointed Interim CEO effective 1st June 2022, and promoted to CEO effective 1st September 2022. He holds a Master of Science in Economics and Business Administration from the Norwegian School of Economics (NHH) and a Master in Professional Accountancy from BI Norwegian Business School. He is a State Authorized Public Accountant in Norway. Before joining PCI Biotech, he was a Director at PwC within Assurance and he has twelve years of experience from auditing and advisory services.

Chief Scientific Officer Anders Høgset, PhD

Anders Høgset began in PCI Biotech in April 2001 as CSO. From 2004 he also was deputy CEO until the second quarter of 2008, when he entered the CSO position again. He holds a Ph. D. in biochemistry from the University of Oslo. Before working at PCI Biotech Dr. Høgset spent four years as a Senior Scientist at Radiumhospitalet developing the PCI technology. From 1989 to 1997 Mr. Høgset was working as a Senior Scientist and Project Manager at Nycomed (now GE Healthcare).